What does BPC-157 do? Benefits and evidence

BPC-157 is an experimental peptide used for injury recovery and gut symptoms. Most evidence comes from animals; human reports are small and weak. Oral and under-skin schedules lack published dose and safety results. A July 2026 compounding panel recommendation did not grant FDA approval. Long-term risks and online product quality remain uncertain.

• In a small study of knee injections, patients reported less pain, though tissue healing was not shown. (Studied in a trial)
• In animal and lab studies, it helped new blood vessels grow, a possible reason for the repair seen in animals. (animal)
• People report taking it for tendon, muscle and joint pain; one user reported less pain that came back after stopping. (Reported by users)
• One user taking it by mouth reported less reflux and fewer gut flares; others reported no benefit. (Reported by users)

Uses in the sources

• Studied in a small knee-injection series and three dental nerve cases. Neither report establishes tissue repair or faster return to sport. (Studied in a trial) (source)
• Studied as a rectal enema for ulcerative colitis and bladder-wall injections for bladder pain. These routes do not validate oral capsules. (Studied in a trial) (source)
• Users report taking it under the skin for tendon, muscle and joint complaints, often with TB-500. (Reported by users) (source)
• Oral and under-tongue users report gut benefits. Human absorption and dependable symptom effects are unproven. (Reported by users) (source)